IMPURITIES AVAILABLE FOR 'Osimertinib'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Osimertinib. Osimertinib is a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used primarily in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations, including the T790M resistance mutation. It selectively targets both sensitizing EGFR mutations and T790M while sparing wild-type EGFR, resulting in improved efficacy and reduced toxicity. Osimertinib has demonstrated significant progression-free and overall survival benefits in advanced NSCLC patients and is also approved for use in the adjuvant setting following tumor resection. It is administered orally and is generally well tolerated. Common side effects include diarrhea, rash, dry skin, and nail toxicity, with rare but serious risks such as interstitial lung disease and QT prolongation. Osimertinib represents a major advancement in targeted lung cancer therapy, particularly for patients who develop resistance to earlier EGFR inhibitors. Buy high quality Osimertinib from Omsynth Lifesciences.